Literature DB >> 15064235

Toll-like receptors: function and roles in lung disease.

Subhendu Basu1, Matthew J Fenton.   

Abstract

Toll-like receptor (TLR) proteins have been shown to play a pivotal role in both innate and adaptive immune responses in higher vertebrates. TLR proteins enable the host to recognize a large number of pathogen-associated molecular patterns such as bacterial lipopolysaccharides, viral RNA, CpG-containing DNA, and flagellin, among others. Engagement of TLR proteins leads to the upregulation of costimulatory molecules and proinflammatory cytokines, as well as reactive nitrogen and oxygen products. The role of TLR proteins in lung-associated pathologies such as airway hyperreactivity, allergic asthma, and tuberculosis is being intensively studied. This review summarizes many of the findings made to date on the roles of TLR proteins in a variety of lung diseases. Generally, TLR proteins serve a protective role in infectious diseases, such as tuberculosis. The progression of chronic inflammatory lung diseases, such as allergic asthma, can also be influenced by TLR-dependent responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15064235     DOI: 10.1152/ajplung.00323.2003

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  66 in total

Review 1.  Reactive oxygen species in inflammation and tissue injury.

Authors:  Manish Mittal; Mohammad Rizwan Siddiqui; Khiem Tran; Sekhar P Reddy; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2013-10-22       Impact factor: 8.401

2.  Toll-like receptor polymorphisms and tuberculosis susceptibility: A comprehensive meta-analysis.

Authors:  Qin Sun; Qing Zhang; He-Ping Xiao; Chong Bai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

Review 3.  Innate immune responses to environmental allergens.

Authors:  Henk F Kauffman
Journal:  Clin Rev Allergy Immunol       Date:  2006-04       Impact factor: 8.667

4.  An association study of asthma and related phenotypes with polymorphisms in negative regulator molecules of the TLR signaling pathway.

Authors:  Kazuko Nakashima; Tomomitsu Hirota; Kazuhiko Obara; Makiko Shimizu; Aya Jodo; Makoto Kameda; Satoru Doi; Kimie Fujita; Taro Shirakawa; Tadao Enomoto; Fumio Kishi; Shigemi Yoshihara; Kenji Matsumoto; Hirohisa Saito; Yoichi Suzuki; Yusuke Nakamura; Mayumi Tamari
Journal:  J Hum Genet       Date:  2006-01-24       Impact factor: 3.172

5.  Lung infections and innate host defense.

Authors:  Ma Valdivia-Arenas; A Amer; Ln Henning; Md Wewers; Ls Schlesinger
Journal:  Drug Discov Today Dis Mech       Date:  2007

6.  Penehyclidine ameliorates acute lung injury by inhibiting Toll-like receptor 2/4 expression and nuclear factor-κB activation.

Authors:  N A Wang; Yue Su; Xiang-Ming Che; Hui Zheng; Zhi-Guo Shi
Journal:  Exp Ther Med       Date:  2016-03-11       Impact factor: 2.447

7.  Sepsis and pathophysiology of anthrax in a nonhuman primate model.

Authors:  Deborah J Stearns-Kurosawa; Florea Lupu; Fletcher B Taylor; Gary Kinasewitz; Shinichiro Kurosawa
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

8.  Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state.

Authors:  Sif Hansdottir; Martha M Monick; Nina Lovan; Linda Powers; Alicia Gerke; Gary W Hunninghake
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

9.  Regulation of TLR2 expression and function in human airway epithelial cells.

Authors:  Tamene Melkamu; Diane Squillace; Hirohito Kita; Scott M O'Grady
Journal:  J Membr Biol       Date:  2009-06-10       Impact factor: 1.843

10.  Immune-mediated disorders among women carriers of fragile X premutation alleles.

Authors:  Tri Indah Winarni; Weerasak Chonchaiya; Tanjung Ayu Sumekar; Paul Ashwood; Guadalupe Mendoza Morales; Flora Tassone; Danh V Nguyen; Sultana M H Faradz; Judy Van de Water; Kylee Cook; Alyssa Hamlin; Yi Mu; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2012-08-17       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.